Keep abreast of the fast developing generics market and the challenges it faces by drawing on analysis from Thomson Reuters sources such as Newport Horizon and presentations by our industry specialists.
Gain industry insight from presentations given by our generics specialists
Enhance your presentations and reports with clearly illustrated slides demonstrating key trends in the generics industry
- Generics Landscape for 2008: Anticipated 2008 Generic Launches
- Generics Landscape for 2008: Paragraph IV Patent Challenges as of July 1, 2008
- Generic Opportunities in the U.S.
- Major New Generic Launches – 2007
- Final ANDA Approvals by Country – 2007
- Total ANDA Approvals by Indian Generics
- Number of Plants Inspected by US FDA: 2001 – 2007
- Availability of High-Quality API for India, China and Rest of World
- US DMF Filings by Indian, Chinese and Rest of World: 1998 - 2007
- Paragraph IV Patent Challenges - 2007
- Patent Challenges by Country - 2007
- Top 10 Companies: by Number of Final ANDA Approvals
- Top 10 Companies: by Number of Patent Challenges
- Full Analysis: Blurring of The Lines between Generics and Innovators
- Full Analysis: Key emerging markets including India, China, Russia, Brazil & Japan
Enhance your presentations and reports with clearly presented information on recent trends in the pharmaceutical industry
- Clinical: A deeper looks at look some key geographic and enrolment trends affecting clinical development timelines globally.
- Development Pipeline: The analysis represented in this area looks at trends from a number of angles including mode of actions, therapy area, stage of development, and R&D expenditure.
- Generics: An examination of global generics opportunities and launch trends as well as taking a look at effects on the growth and development of the generic industry such as patent challenges and the API supply.
- Marketing & Messages: Results displayed here look at key commercial trends such as revenues by therapy area and company size as well as the impact messages published in journal articles, abstracts, monographs, posters…have on the attitudes and treatment habits of prescribing clinicians.
- Patents: A slide representation of the analysis of key data sources related to patent activity such as the number of pharmaceutical patent applications and granted patents from the five major patent issuing authorities
- R&D Expenditure: The analysis represented in this area looks at trends from a number of angles.
- Regulatory: Analysis of some key geographic trends as well as some trends related to submission and market approval times and data on the number of NAS and NME launches.
- More...
What's Happening?
ANALYSIS:
Find out about the opening moves of Amneal Pharmaceutical LLC, Ebewe Pharma GmbH, Hikma Pharmaceuticals PLC in the US generics industry. Movers and Shakers
OPINION:
Kate Kuhrt, director of industry research at Thomson Reuters points to Japan as one of the most interesting markets, both for generic and for API manufacturers. Generic drugmakers eye new opportunties in Japan
Movers & Shakers
Amneal Pharmaceutical LLC, Ebewe Pharma GmbH, Hikma Pharmaceuticals PLC make their first steps into the US generics industry. More on Generics...